Roy F. Chemaly MD, MPH, FIDSA, FACP

Dr. Roy Chemaly is a Professor of Medicine in the Department of Infectious Diseases, Infection Control & Employee Health at The University of Texas MD Anderson Cancer Center in Houston, Texas. Dr. Chemaly completed his training in infectious diseases and medical microbiology at the Cleveland Clinic Foundation in Ohio. He is board-certified in internal medicine/infectious diseases, medical quality, and medical microbiology. Dr. Chemaly is the Chief Infection Control Officer at UT MD Anderson Cancer Center, the chair of the Quality and Safety Council of the Division of Internal Medicine, and the director of the clinical virology research program. In addition, he is one of the founding members and past-chair of the Transplant Infectious Diseases Special Interest Group of the American Society of Transplant and Cellular Therapy.

Dr. Chemaly devoted his career studying viral infections in immunocompromised patients, specifically those undergoing hematopoietic cell transplantation for hematologic malignancies. He published extensively on mechanisms to treat and prevent viral infections in this population. Dr. Chemaly’s work has been reported in numerous peer-reviewed journals including the New England Journal of Medicine, Blood, Journal of Infectious Diseases, and Clinical Infectious Diseases.